Literature DB >> 19377889

Rosiglitazone: to be or not to be?

A J Scheen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19377889     DOI： 10.1007/s00125-009-1358-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  13 in total

1.  Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-01       Impact factor: 10.122

2.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.

Authors:  M G Goldner; G L Knatterud; T E Prout
Journal:  JAMA       Date:  1971-11       Impact factor: 56.272

Review 3.  Lactic acidosis in biguanide-treated diabetics: a review of 330 cases.

Authors:  D Luft; R M Schmülling; M Eggstein
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

4.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

5.  Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials.

Authors:  Deng-feng Geng; Dong-mei Jin; Wei Wu; Zhi Wang; Jing-feng Wang
Journal:  Atherosclerosis       Date:  2008-05-28       Impact factor: 5.162

6.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

7.  Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2008-10-22       Impact factor: 10.122

8.  Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

Authors:  Philip D Home; Stuart J Pocock; Henning Beck-Nielsen; Ramón Gomis; Markolf Hanefeld; Nigel P Jones; Michel Komajda; John J V McMurray
Journal:  N Engl J Med       Date:  2007-06-05       Impact factor: 91.245

Review 9.  Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.

Authors:  Rodrigo M Lago; Premranjan P Singh; Richard W Nesto
Journal:  Lancet       Date:  2007-09-29       Impact factor: 79.321

10.  Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches.

Authors:  Jan O Friedrich; Joseph Beyene; Neill K J Adhikari
Journal:  BMC Res Notes       Date:  2009-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.